Amgen Cdr Stock Performance
| AMGN Stock | 27.85 0.30 1.09% |
Amgen CDR has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.3, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Amgen CDR's returns are expected to increase less than the market. However, during the bear market, the loss of holding Amgen CDR is expected to be smaller as well. Amgen CDR right now shows a risk of 2.09%. Please confirm Amgen CDR coefficient of variation, jensen alpha, and the relationship between the downside deviation and information ratio , to decide if Amgen CDR will be following its price patterns.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Amgen CDR are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Amgen CDR may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
1 | UPDATE Amgens Stock Gains Lift Co Value, But Concerns Remain - ADVFN | 01/08/2026 |
Amgen |
Amgen CDR Relative Risk vs. Return Landscape
If you would invest 2,578 in Amgen CDR on November 8, 2025 and sell it today you would earn a total of 207.00 from holding Amgen CDR or generate 8.03% return on investment over 90 days. Amgen CDR is generating 0.167% of daily returns and assumes 2.0877% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Amgen, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Amgen CDR Target Price Odds to finish over Current Price
The tendency of Amgen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 27.85 | 90 days | 27.85 | near 1 |
Based on a normal probability distribution, the odds of Amgen CDR to move above the current price in 90 days from now is near 1 (This Amgen CDR probability density function shows the probability of Amgen Stock to fall within a particular range of prices over 90 days) .
Amgen CDR Price Density |
| Price |
Predictive Modules for Amgen CDR
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amgen CDR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Amgen CDR Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Amgen CDR is not an exception. The market had few large corrections towards the Amgen CDR's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amgen CDR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amgen CDR within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.15 | |
β | Beta against Dow Jones | 0.30 | |
σ | Overall volatility | 0.88 | |
Ir | Information ratio | 0.06 |
Amgen CDR Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amgen Stock often depends not only on the future outlook of the current and potential Amgen CDR's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amgen CDR's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 539 M | |
| Cash And Short Term Investments | 9.1 B |
Amgen CDR Fundamentals Growth
Amgen Stock prices reflect investors' perceptions of the future prospects and financial health of Amgen CDR, and Amgen CDR fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amgen Stock performance.
| Return On Equity | 81.71 | ||||
| Revenue | 36.75 B | ||||
| Net Income | 4.09 B | ||||
| Cash And Equivalents | 9.13 B | ||||
| Total Debt | 81.93 B | ||||
| Cash Flow From Operations | 11.49 B | ||||
| Earnings Per Share | 12.94 X | ||||
| Total Asset | 90.59 B | ||||
| Retained Earnings | (27.59 B) | ||||
About Amgen CDR Performance
By examining Amgen CDR's fundamental ratios, stakeholders can obtain critical insights into Amgen CDR's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Amgen CDR is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Amgen CDR is entity of Canada. It is traded as Stock on TO exchange.Things to note about Amgen CDR performance evaluation
Checking the ongoing alerts about Amgen CDR for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amgen CDR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Amgen CDR's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Amgen CDR's stock performance include:- Analyzing Amgen CDR's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amgen CDR's stock is overvalued or undervalued compared to its peers.
- Examining Amgen CDR's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amgen CDR's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amgen CDR's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amgen CDR's stock. These opinions can provide insight into Amgen CDR's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Amgen Stock
Amgen CDR financial ratios help investors to determine whether Amgen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amgen with respect to the benefits of owning Amgen CDR security.